Understanding the nuclear receptor (NR) mediated regulationof CYP expression in these tissues is necessary for identifying cancer riskfactors and developing CYP1A1/1B1-targeted anti-cancer therapeutics. The gene discussed is CYP1A1; the disease is cancer.